ASHLEY MOORE: Open Payments
NPI 1154925964 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$337 in 16 payments from 9 companies in 2025. Trend: 2023 $958 · 2024 $981 · 2025 $337
Food & beverage: $337
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $101 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $72 |
| Madrigal Pharmaceuticals | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $24 |
| QOL Medical, LLC | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| GENZYME CORPORATION | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: ENTYVIO, XELJANZ, REZDIFFRA, VELSIPITY, DUPIXENT, VOQUEZNA, TREMFYA, Sucraid.
Industry payments across OH — which companies pay providers there.
